Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease.

Dropinski, Jerzy

Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease. [electronic resource] - Thrombosis research 2007 - 301-3 p. digital

Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial

0049-3848

10.1016/j.thromres.2006.03.005 doi


Alleles
Aspirin--administration & dosage
Bleeding Time
Coronary Artery Disease--genetics
Cyclooxygenase Inhibitors--administration & dosage
Homozygote
Humans
Integrin beta3--genetics
Male
Polymorphism, Genetic
Retrospective Studies
Thrombin Time